INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $760 | -45.5% | 1,702 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,395 | -47.4% | 1,702 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,654 | -11.5% | 1,702 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 1,702 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | +50.0% | 1,702 | +150.3% | 0.00% | +100.0% |
| Q1 2022 | $2,000 | -33.3% | 680 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -66.7% | 680 | -29.5% | 0.00% | -66.7% |
| Q2 2021 | $9,000 | 0.0% | 965 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $9,000 | +50.0% | 965 | +41.9% | 0.01% | +60.0% |
| Q4 2020 | $6,000 | -33.3% | 680 | -12.8% | 0.01% | -44.4% |
| Q3 2020 | $9,000 | -50.0% | 780 | +14.7% | 0.01% | -55.0% |
| Q2 2020 | $18,000 | – | 680 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |